Upcoming Dividend • Apr 29
Upcoming dividend of ฿0.073 per share Eligible shareholders must have bought the stock before 06 May 2026. Payment date: 25 May 2026. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of Thai dividend payers (7.5%). Lower than average of industry peers (5.3%). Reported Earnings • Mar 04
Full year 2025 earnings released: EPS: ฿0.20 (vs ฿0.062 in FY 2024) Full year 2025 results: EPS: ฿0.20 (up from ฿0.062 in FY 2024). Revenue: ฿2.21b (up 16% from FY 2024). Net income: ฿122.4m (up 228% from FY 2024). Profit margin: 5.5% (up from 1.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings. 공지 • Mar 03
Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 Inter Pharma Public Company Limited announced Annual dividend of THB 0.0730 per share payable on May 25, 2026, ex-date on May 06, 2026 and record date on May 07, 2026. 공지 • Mar 02
Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026 Inter Pharma Public Company Limited, Annual General Meeting, Apr 27, 2026, at 14:00 SE Asia Standard Time. Reported Earnings • Nov 12
Third quarter 2025 earnings released: EPS: ฿0.072 (vs ฿0.006 in 3Q 2024) Third quarter 2025 results: EPS: ฿0.072 (up from ฿0.006 in 3Q 2024). Revenue: ฿563.5m (up 28% from 3Q 2024). Net income: ฿43.6m (up ฿39.8m from 3Q 2024). Profit margin: 7.7% (up from 0.9% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ฿3.48, the stock trades at a trailing P/E ratio of 29.2x. Average trailing P/E is 17x in the Personal Products industry in Thailand. Total loss to shareholders of 64% over the past three years. New Risk • Sep 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.5% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Market cap is less than US$100m (฿2.47b market cap, or US$77.3m). Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ฿3.88, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 17x in the Personal Products industry in Thailand. Total loss to shareholders of 63% over the past three years. Reported Earnings • Aug 15
Second quarter 2025 earnings released: EPS: ฿0.047 (vs ฿0.006 in 2Q 2024) Second quarter 2025 results: EPS: ฿0.047 (up from ฿0.006 in 2Q 2024). Revenue: ฿540.8m (up 21% from 2Q 2024). Net income: ฿28.2m (up ฿24.8m from 2Q 2024). Profit margin: 5.2% (up from 0.8% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. Reported Earnings • May 14
First quarter 2025 earnings released: EPS: ฿0.043 (vs ฿0.026 in 1Q 2024) First quarter 2025 results: EPS: ฿0.043 (up from ฿0.026 in 1Q 2024). Revenue: ฿533.7m (up 9.5% from 1Q 2024). Net income: ฿25.9m (up 64% from 1Q 2024). Profit margin: 4.9% (up from 3.2% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ฿3.00, the stock trades at a trailing P/E ratio of 48.7x. Average trailing P/E is 17x in the Personal Products industry in Thailand. Total loss to shareholders of 75% over the past three years. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ฿3.62, the stock trades at a trailing P/E ratio of 58.8x. Average trailing P/E is 17x in the Personal Products industry in Thailand. Total loss to shareholders of 69% over the past three years. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ฿2.86, the stock trades at a trailing P/E ratio of 46.4x. Average trailing P/E is 17x in the Personal Products industry in Thailand. Total loss to shareholders of 75% over the past three years. 공지 • Feb 27
Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 Inter Pharma Public Company Limited at its Annual General Meeting of Shareholders to be on April 26, 2024, proposed the allocation of net profit for the year ended December 31, 2024 amount of THB 1.2 Million as the Company's legal reserve and approve the omitted dividend payment for operating results in 2024 to be used as working capital of the Company. Reported Earnings • Feb 27
Full year 2024 earnings released: EPS: ฿0.062 (vs ฿0.084 in FY 2023) Full year 2024 results: EPS: ฿0.062 (down from ฿0.084 in FY 2023). Revenue: ฿1.91b (up 6.3% from FY 2023). Net income: ฿37.3m (down 27% from FY 2023). Profit margin: 1.9% (down from 2.8% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 41% per year, which means it has not declined as severely as earnings. 공지 • Feb 26
Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025 Inter Pharma Public Company Limited, Annual General Meeting, Apr 28, 2025, at 14:00 SE Asia Standard Time. New Risk • Sep 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (฿2.69b market cap, or US$79.1m). Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: ฿0.006 (vs ฿0.019 in 2Q 2023) Second quarter 2024 results: EPS: ฿0.006 (down from ฿0.019 in 2Q 2023). Revenue: ฿448.1m (flat on 2Q 2023). Net income: ฿3.42m (down 70% from 2Q 2023). Profit margin: 0.8% (down from 2.5% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment deteriorates as stock falls 26% After last week's 26% share price decline to ฿3.44, the stock trades at a trailing P/E ratio of 76x. Average trailing P/E is 19x in the Personal Products industry in Thailand. Total loss to shareholders of 75% over the past three years. New Risk • May 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin). Market cap is less than US$100m (฿3.12b market cap, or US$84.8m). Reported Earnings • May 15
First quarter 2024 earnings released: EPS: ฿0.042 (vs ฿0.066 in 1Q 2023) First quarter 2024 results: EPS: ฿0.042 (down from ฿0.066 in 1Q 2023). Revenue: ฿487.4m (up 2.1% from 1Q 2023). Net income: ฿15.8m (down 61% from 1Q 2023). Profit margin: 3.2% (down from 8.4% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • May 07
Investor sentiment deteriorates as stock falls 40% After last week's 40% share price decline to ฿5.91, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 19x in the Personal Products industry in Asia. Total loss to shareholders of 72% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ฿7.62 per share. 공지 • Apr 27
Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 Inter Pharma Public Company Limited announced that at the AGM was held on April 26, 2024, the company approved the dividend payment in cash to shareholders at the rate of THB 0.0348 per share for the Year 2023. The Board also specified the date to determine the list of shareholders entitled to receive the dividend as May 8, 2024 (Record Date), with dividend payments scheduled on May 24, 2024. Buy Or Sell Opportunity • Mar 21
Now 20% overvalued The stock has been flat over the last 90 days, currently trading at ฿9.00. The fair value is estimated to be ฿7.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Earnings per share has grown by 6.0%. Revenue is forecast to grow by 51% in 2 years. Earnings are forecast to grow by 312% in the next 2 years. Declared Dividend • Mar 04
Dividend reduced to ฿0.035 Dividend of ฿0.035 is 81% lower than last year. Ex-date: 7th May 2024 Payment date: 24th May 2024 Dividend yield will be 0.4%, which is lower than the industry average of 3.1%. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.0% per year over the past 4 years. However, payments have been volatile during that time. EPS is expected to grow by 154% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 03
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ฿0.14 (down from ฿0.36 in FY 2022). Revenue: ฿1.80b (up 17% from FY 2022). Net income: ฿50.8m (down 57% from FY 2022). Profit margin: 2.8% (down from 7.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.9%. Earnings per share (EPS) also missed analyst estimates by 57%. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Board Change • Dec 22
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Pao Sriprasertsuk was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Nov 15
Third quarter 2023 earnings released: EPS: ฿0.037 (vs ฿0.09 in 3Q 2022) Third quarter 2023 results: EPS: ฿0.037 (down from ฿0.09 in 3Q 2022). Revenue: ฿443.0m (up 9.8% from 3Q 2022). Net income: ฿13.7m (down 55% from 3Q 2022). Profit margin: 3.1% (down from 7.5% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. New Risk • Oct 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ฿3.69b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Profit margins are more than 30% lower than last year (6.2% net profit margin). Market cap is less than US$100m (฿3.69b market cap, or US$99.3m). Major Estimate Revision • Sep 08
Consensus EPS estimates fall by 32% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ฿1.99b to ฿1.89b. EPS estimate also fell from ฿0.47 per share to ฿0.32 per share. Net income forecast to grow 42% next year vs 24% growth forecast for Personal Products industry in Thailand. Consensus price target down from ฿18.55 to ฿17.70. Share price rose 7.8% to ฿11.10 over the past week. Reported Earnings • Aug 17
Second quarter 2023 earnings released: EPS: ฿0.03 (vs ฿0.10 in 2Q 2022) Second quarter 2023 results: EPS: ฿0.03 (down from ฿0.10 in 2Q 2022). Revenue: ฿447.7m (up 8.9% from 2Q 2022). Net income: ฿11.3m (down 63% from 2Q 2022). Profit margin: 2.5% (down from 7.4% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. New Risk • Aug 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin). Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ฿9.95, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Personal Products industry in Asia. Total returns to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ฿9.43 per share. Price Target Changed • Jul 14
Price target decreased by 9.7% to ฿18.10 Down from ฿20.05, the current price target is an average from 3 analysts. New target price is 48% above last closing price of ฿12.20. Stock is down 31% over the past year. The company is forecast to post earnings per share of ฿0.47 for next year compared to ฿0.36 last year. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ฿8.60, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Personal Products industry in Asia. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ฿7.98 per share. Valuation Update With 7 Day Price Move • May 23
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ฿9.40, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 24x in the Personal Products industry in Asia. Total returns to shareholders of 88% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ฿6.77 per share. Reported Earnings • May 18
First quarter 2023 earnings released: EPS: ฿0.11 (vs ฿0.10 in 1Q 2022) First quarter 2023 results: EPS: ฿0.11 (up from ฿0.10 in 1Q 2022). Revenue: ฿477.5m (up 75% from 1Q 2022). Net income: ฿40.1m (up 34% from 1Q 2022). Profit margin: 8.4% (down from 11% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Personal Products industry in Asia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • May 02
Upcoming dividend of ฿0.18 per share at 1.6% yield Eligible shareholders must have bought the stock before 08 May 2023. Payment date: 26 May 2023. Trailing yield: 1.6%. Lower than top quartile of Thai dividend payers (6.2%). Lower than average of industry peers (3.7%). Price Target Changed • Mar 28
Price target decreased by 13% to ฿18.65 Down from ฿21.45, the current price target is an average from 2 analysts. New target price is 48% above last closing price of ฿12.60. Stock is down 34% over the past year. The company is forecast to post earnings per share of ฿0.52 for next year compared to ฿0.36 last year. Major Estimate Revision • Dec 03
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ฿0.52 to ฿0.39 per share. Revenue forecast steady at ฿1.56b. Net income forecast to grow 51% next year vs 26% growth forecast for Personal Products industry in Thailand. Consensus price target down from ฿21.45 to ฿20.05. Share price rose 4.2% to ฿15.00 over the past week. Board Change • Nov 16
Less than half of directors are independent There are 10 new directors who have joined the board in the last 3 years. Of these new board members, 4 were independent directors. The company's board is composed of: 10 new directors. No experienced directors. No highly experienced directors. 4 independent directors (6 non-independent directors). Independent Chairman of the Board Udom Kachintorn is the most experienced director on the board, commencing their role in 2019. Independent Director Pao Sriprasertsuk was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: ฿0.10 (vs ฿0.086 in 2Q 2021) Second quarter 2022 results: EPS: ฿0.10 (up from ฿0.086 in 2Q 2021). Revenue: ฿411.2m (up 104% from 2Q 2021). Net income: ฿30.6m (up 24% from 2Q 2021). Profit margin: 7.4% (down from 12% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 44%, compared to a 11% growth forecast for the industry in Thailand. Major Estimate Revision • Jun 16
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from ฿0.53 to ฿0.63. Revenue forecast unchanged at ฿1.53b. Net income forecast to grow 70% next year vs 16% growth forecast for Personal Products industry in Thailand. Consensus price target down from ฿26.00 to ฿20.80. Share price fell 6.7% to ฿19.40 over the past week. Reported Earnings • May 17
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: ฿0.10 (up from ฿0.065 in 1Q 2021). Revenue: ฿273.2m (up 54% from 1Q 2021). Net income: ฿30.0m (up 60% from 1Q 2021). Profit margin: 11% (in line with 1Q 2021). Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 24%. Over the next year, revenue is forecast to grow 56%, compared to a 10% growth forecast for the industry in Thailand. Price Target Changed • Apr 27
Price target increased to ฿26.00 Up from ฿24.00, the current price target is provided by 1 analyst. New target price is 32% above last closing price of ฿19.70. Stock is down 7.9% over the past year. The company is forecast to post earnings per share of ฿0.53 for next year compared to ฿0.36 last year. Board Change • Apr 27
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Chairman of the Board Udom Kachintorn is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Feb 27
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: ฿0.36 (up from ฿0.19 in FY 2020). Revenue: ฿921.0m (up 106% from FY 2020). Net income: ฿105.2m (up 96% from FY 2020). Profit margin: 11% (in line with FY 2020). Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 24%. Over the next year, revenue is forecast to grow 66%, compared to a 11% growth forecast for the industry in Thailand. Major Estimate Revision • Dec 09
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ฿792.0m to ฿874.0m. EPS estimate fell from ฿0.35 to ฿0.29. Net income forecast to grow 127% next year vs 19% growth forecast for Personal Products industry in Thailand. Consensus price target up from ฿24.00 to ฿26.00. Share price rose 4.1% to ฿20.10 over the past week. Major Estimate Revision • Dec 09
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ฿792.0m to ฿874.0m. EPS estimate fell from ฿0.35 to ฿0.29. Net income forecast to grow 127% next year vs 19% growth forecast for Personal Products industry in Thailand. Consensus price target up from ฿24.00 to ฿26.00. Share price rose 4.1% to ฿20.10 over the past week. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS ฿0.088 (vs ฿0.064 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ฿244.4m (up 121% from 3Q 2020). Net income: ฿25.7m (up 39% from 3Q 2020). Profit margin: 11% (down from 17% in 3Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 29% share price decline to ฿15.40, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 23x in the Personal Products industry in Asia. Total returns to shareholders of 68% over the past year. Reported Earnings • Aug 18
Second quarter 2021 earnings released: EPS ฿0.086 (vs ฿0.059 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ฿201.3m (up 99% from 2Q 2020). Net income: ฿24.8m (up 46% from 2Q 2020). Profit margin: 12% (down from 17% in 2Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • May 14
First quarter 2021 earnings released: EPS ฿0.091 (vs ฿0.048 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: ฿177.9m (up 80% from 1Q 2020). Net income: ฿18.7m (up 35% from 1Q 2020). Profit margin: 11% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Analyst Estimate Surprise Post Earnings • Feb 27
Revenue and earnings miss expectations Revenue missed analyst estimates by 0.4%. Earnings per share (EPS) also missed analyst estimates by 19%. Over the next year, revenue is forecast to grow 55%, compared to a 10% growth forecast for the Personal Products industry in Thailand. Reported Earnings • Feb 27
Full year 2020 earnings released: EPS ฿0.26 (vs ฿0.28 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: ฿446.9m (up 19% from FY 2019). Net income: ฿53.8m (up 24% from FY 2019). Profit margin: 12% (in line with FY 2019). Valuation Update With 7 Day Price Move • Feb 10
Investor sentiment improved over the past week After last week's 19% share price gain to ฿21.00, the stock is trading at a trailing P/E ratio of 68.5x, up from the previous P/E ratio of 57.4x. This compares to an average P/E of 27x in the Personal Products industry in Thailand. Total returns to shareholders over the past year are 251%. Is New 90 Day High Low • Feb 09
New 90-day high: ฿19.70 The company is up 64% from its price of ฿12.00 on 11 November 2020. The Thai market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 21% over the same period. Executive Departure • Feb 03
Independent Director has left the company On the 31st of January, Amornsakdi Ketcharoon's tenure in the role of Independent Director ended. We don't have any record of a personal shareholding under Amornsakdi's name. A total of 2 executives have left over the last 12 months. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 16% share price gain to ฿15.20, the stock is trading at a trailing P/E ratio of 49.6x, up from the previous P/E ratio of 42.8x. This compares to an average P/E of 22x in the Personal Products industry in Thailand. Total returns to shareholders over the past year are 176%. Is New 90 Day High Low • Jan 04
New 90-day high: ฿14.00 The company is up 14% from its price of ฿12.30 on 06 October 2020. The Thai market is up 17% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 6.0% over the same period. Is New 90 Day High Low • Dec 03
New 90-day high: ฿13.60 The company is up 1.0% from its price of ฿13.40 on 03 September 2020. The Thai market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. Reported Earnings • Nov 13
Third quarter 2020 earnings released: EPS ฿0.09 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ฿110.6m (up 19% from 3Q 2019). Net income: ฿18.5m (up 36% from 3Q 2019). Profit margin: 17% (up from 15% in 3Q 2019). The increase in margin was driven by higher revenue.